Sodium Bicarbonate in Chemotherapy: Hidden Role in Reducing Toxicity. Discover how sodium bicarbonate is used in chemotherapy to reduce toxicity, protect organs, and challenge the “only option” myth in cancer treatment.

Part two

A Controversial Lifeline

Chemotherapy has long been presented as the only real weapon against cancer. Yet its reputation is double-edged. For some cancers it offers life-saving results, while for others it inflicts punishing toxicity with only modest extensions of survival. The paradox is sharpened when we realize that even within conventional oncology, doctors must use a cheap, simple substance—sodium bicarbonate—to blunt the very damage chemotherapy inflicts. This reality raises uncomfortable questions about both the safety of chemo and the medical system’s reluctance to explore alternatives.

Chemotherapy’s Double-Edged Sword

Few dispute that chemo can help in certain cancers: childhood leukemia, Hodgkin’s lymphoma, and testicular cancer are the textbook success stories. But in many common solid tumors—pancreatic, metastatic lung, colon—the results are sobering. Patients endure brutal side effects, often for only incremental gains. This is why chemotherapy is frequently described not as a cure but as a high-risk balancing act. The treatment harms both malignant and healthy cells, demanding elaborate “supportive care” just to keep patients alive through the regimen.

Sodium Bicarbonate: Not a Fringe Experiment

Contrary to the impression that bicarbonate therapy belongs only to alternative medicine circles, sodium bicarbonate has been formally incorporated into chemotherapy regimens in mainstream hospitals. Its role is straightforward yet profound: it acts as a buffer against acid buildup and organ damage caused by chemotherapy drugs.

How It Works

·         Alkalinizing the body: Many chemo drugs—such as cisplatin, methotrexate, and doxorubicin—create or worsen acidity in tissues and blood. Sodium bicarbonate neutralizes this, protecting kidneys and liver.

·         Methotrexate example: High-dose methotrexate can crystallize in the kidneys, causing severe damage. Standard oncology protocols include intravenous bicarbonate to alkalinize the urine, preventing these crystals from forming.

·         Cisplatin example: Cisplatin is notoriously nephrotoxic. Bicarbonate solutions are often added to hydration fluids to reduce kidney injury.

·         Overall effect: Bicarbonate does not make chemotherapy safe, but it does blunt some of its most destructive effects—especially in the urinary tract and kidneys.

Why Patients Rarely Hear About It

For oncologists, adding sodium bicarbonate is considered routine supportive care, no more exotic than prescribing anti-nausea medication or IV fluids, and the probable reason the therapy has success in milder cases: childhood leukemia, Hodgkin’s lymphoma, and testicular cancer. Yet from a patient’s perspective, the irony is striking: a cheap household substance is deemed essential to protect against the side effects of multi-thousand-dollar cancer drugs.

This disconnect underscores a larger truth: if chemotherapy requires such chemical shielding just to be survivable, what does that reveal about its inherent toxicity? And why isn’t there a more open conversation about other adjunctive, potentially life-protective strategies—nutritional, metabolic, or botanical—that could work alongside or even beyond chemo?

The Bigger Picture

The use of sodium bicarbonate highlights a deep contradiction in modern oncology. On the one hand, the system quietly admits that a non-patentable, inexpensive compound is indispensable to making chemo viable. On the other hand, it resists applying the same openness to other supportive or alternative therapies.

Consider the implications:

·         If chemo needs baking soda to counteract its own toxicity, then chemotherapy is not a “standalone cure” but a carefully managed chemical gamble.

·         The medical system already relies on non-cancer-killing adjuncts to prop up chemotherapy, yet remains skeptical or dismissive of other low-cost adjuncts such as nutritional protocols, detoxification measures, or botanical compounds.

·         This rigid selectivity reflects not just science, but systemic forces: liability fears, regulatory constraints, and the economics of drug development.

Beyond the “Only Option” Narrative

Sodium bicarbonate is proof that supportive measures matter. But it also serves as a symbol of how narrow the cancer treatment paradigm remains. Patients are told that chemotherapy is the only real choice, while integrative options are sidelined or ridiculed. Yet the very existence of bicarbonate in oncology protocols shows that cancer treatment is already dependent on simple, supportive, and non-patentable aids.

If oncology embraced this principle more fully, doors could open to a wider set of adjunctive strategies: metabolic therapies, targeted nutrition, immunomodulating botanicals, and lifestyle-based interventions. Instead of a high-risk balancing act propped up by secrecy, treatment could become a broader, more humane spectrum of options.

A Dose of Perspective

The quiet use of sodium bicarbonate in chemotherapy regimens is more than a technical detail—it is a window into the contradictions of modern cancer care. Chemotherapy may still have its place, but its dependence on a household compound to offset toxicity exposes the fragility of the “only option” narrative. Real progress will come not from denying chemo’s role altogether, but from demanding a system that values all effective adjuncts, regardless of whether they come from a billion-dollar lab or a humble box of baking soda. 

Oncologist Simoncini's Cancer Therapy is nothing but pure baking soda. For being an honest scientist and a caring medical doctor he was stripped of his license, deregistered and miraculously survived two attempts on his life. No money for Big Pharma in promoting sodium bicarbonate (baking soda).

 sharing is caring